USPTO serial 79158397
VIFOR PHARMA
Reviewed by CopyMark Law Group
Reg. 4948439Status 709
- Filing date
- Status date
- Registration date
- May 3, 2016
- Examiner
- JUN, WON KYUNG WENDY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIFOR PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifrices | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectants | SECTION 71 - CANCELLED | — |
| 035 | Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparations | SECTION 71 - CANCELLED | — |
| 039 | Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparations | SECTION 71 - CANCELLED | — |
| 041 | Business training services as relating to pharmaceutical and sanitary products | SECTION 71 - CANCELLED | — |
| 042 | Research and development of medicines, pharmaceutical preparations and sanitary care products for others | SECTION 71 - CANCELLED | — |
| 045 | Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicines | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Galenica AG
- Other trademarks owned by Galenica AG
- Other trademarks owned by Galenica AG
- Other trademarks owned by Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named VIFOR PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2025 | Further Decision Processed by IB | — | |
| Mar 21, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 21, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 21, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 18, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 18, 2022 | C71T | CANCELLED SECTION 71 | — |
| Nov 30, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 13, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 5, 2017 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 17, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 9, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 9, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 3, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 3, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 16, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 12, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 27, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 27, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 13, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 11, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 8, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 8, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 7, 2016 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 7, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 6, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 5, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 5, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 5, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 9, 2015 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 8, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 9, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 6, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 13, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 11, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 10, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2015 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |